fashion -WSS

fashion

author：Wikipedia 2025-09-30 10:10:31 - browse：92134

Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

WSS

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Artificial intelligence use in health care faces greater scrutiny in 2024

Study gives hint on South Asians’ higher risk of cardiovascular disease

Hospitals owned by private equity see complications spike 25%

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

hotspot

fashion

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In Spain, a hospital brews its own CAR

As demand for Covid shots wanes, Moderna seeks its next success

Christmas in the PICU brings some surprising joy

In Memoriam: Notable people who died in 2023

Medicare drug price negotiation hasn't dried up venture capital

Activists slam private health insurers over coverage restrictions

CRISPR gene editing developments we’re watching in 2024

Medical leaders decry Supreme Court decision on affirmative action

Christmas in the PICU brings some surprising joy

hotspot

Can sheer will power keep patients alive in their dying hours?

Grail spinoff by Illumina should end disastrous merger attempt

Why Eli Lilly’s earnings didn’t quite live up to the hype

Resistance to opioid

Keeping primary care docs in field isn't impossible, says AAFP CEO

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

focus

hotspot

leisure time

entertainment